Oncology & Cancer
New blood test predicts who will benefit from targeted prostate cancer treatments
A new blood test could predict which men with advanced prostate cancer will respond to new targeted treatments for the disease.
May 3, 2017
0
1
Annals of Oncology
Oncology & Cancer
England's Cancer Drugs Fund 'failed to deliver meaningful value to patients and society'
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily ...
Apr 27, 2017
0
1
Oncology & Cancer
Death rates from cancer will fall faster in men than in women in Europe in 2017
Death rates from cancer in the European Union (EU) are falling faster in men than in women, according to the latest predictions for European cancer deaths in 2017, published in the leading cancer journal Annals of Oncology ...
Feb 22, 2017
0
0
Oncology & Cancer
Investigators pinpoint cause, possible treatment for rare form of sarcoma
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation ...
Nov 22, 2016
0
2
Oncology & Cancer
Roots of resistance to cancer drugs runs deeper than a single gene
Searching for more individual genes to predict responses to breast cancer therapy may not work, a new study suggests. Instead, scientists and clinicians need to pay attention to abnormalities in networks of genes, Yale researchers ...
Oct 21, 2016
0
2
Oncology & Cancer
Immune and targeted therapies with radiation therapy improves outcomes for melanoma brain metastases patients
Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management. Patients who are diagnosed with these metastases have an expected median survival of only 4 to 5 months. ...
Sep 21, 2016
0
1
Oncology & Cancer
Deaths from ovarian cancer decline worldwide due to oral contraceptive use
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union (EU) and, though to a smaller degree, in Japan by 2020, according to new research published ...
Sep 5, 2016
0
96
Oncology & Cancer
Longer survival of cancer patients given methylnaltrexone suggests role for mu opiate receptor in cancer progression
A study of advanced cancer patients published in the journal Annals of Oncology and presented at this year's World Congress of Anaesthesiologists in Hong Kong suggests that opioid painkillers and their receptor in cells - ...
Sep 1, 2016
0
0
Oncology & Cancer
Expecting the worst increases side-effects in breast cancer patients on hormone therapies
A study of women receiving hormone therapies such as tamoxifen as part of their treatment for breast cancer has found that the number and seriousness of side-effects they experienced were influenced by their expectations.
Aug 22, 2016
0
0
Oncology & Cancer
ESMO releases new consensus guidelines on the management of metastatic colorectal cancer
ESMO, the leading European professional organisation for medical oncology, has released new consensus guidelines for the management of metastatic colorectal cancer that reflect an increasingly personalized approach to treatment, ...
Jul 6, 2016
0
0
